GlobeNewswire 05/05/2021 Genmab Announces Financial Results for the First Quarter of 2021
GlobeNewswire 20/04/2021 Genmab Announces Net Sales of DARZALEX® (daratumumab) for First Quarter of 2021
GlobeNewswire 09/04/2021 Genmab and Seagen Announce U.S. FDA Filing Acceptance for Priority Review of Tisotumab Vedotin Biolo...
GlobeNewswire 30/03/2021 Genmab Announces European Marketing Authorization for Kesimpta® (ofatumumab) in Relapsing Multiple S...
GlobeNewswire 25/02/2021 Transactions with shares and linked securities in Genmab A/S made by managerial employees and their ...
GlobeNewswire 23/02/2021 Genmab announces initiation of share buy-back program
GlobeNewswire 23/02/2021 Genmab Publishes 2020 Annual Report
GlobeNewswire 22/02/2021 Genmab Announces Appointment of Tahamtan Ahmadi to Newly Created Position of Chief Medical Officer, ...
GlobeNewswire 10/02/2021 Genmab and Seagen Submit Tisotumab Vedotin Biologics License Application to the U.S. FDA for Patient...
GlobeNewswire 29/01/2021 CHMP Issues Positive Opinion Recommending Ofatumumab in Relapsing Multiple Sclerosis
GlobeNewswire 26/01/2021 Genmab Announces 2020 Net Sales of DARZALEX® (daratumumab)
GlobeNewswire 15/01/2021 Genmab Announces that Janssen has been Granted U.S. FDA Approval for DARZALEX FASPRO® (daratumumab a...
GlobeNewswire 13/01/2021 Genmab Achieves USD 40 Million Milestone in Collaboration with AbbVie
GlobeNewswire 04/01/2021 Genmab Announces Phase 3 Trial of Tisotumab Vedotin in Recurrent or Metastatic Cervical Cancer
GlobeNewswire 24/11/2020 Genmab Announces Enapotamab Vedotin Update
GlobeNewswire 05/11/2020 Genmab Announces Phase 3 Study Evaluating Epcoritamab in Patients with Relapsed or Refractory Diffus...
GlobeNewswire 04/11/2020 Genmab Announces Financial Results for the First Nine Months of 2020
GlobeNewswire 21/10/2020 Genmab Announces IFM, HOVON and Janssen Achieve Positive Topline Results in Second Part of Phase 3 C...
GlobeNewswire 13/10/2020 Genmab Announces Net Sales of DARZALEX® (daratumumab) for Third Quarter of 2020
GlobeNewswire 22/09/2020 Genmab Commences Binding Arbitration of Two Matters Under License Agreement with Janssen
GlobeNewswire 21/09/2020 Genmab and Seattle Genetics Present Data from Tisotumab Vedotin innovaTV 204 Pivotal Trial in Recurr...
GlobeNewswire 20/08/2020 Genmab Announces Janssen Granted U.S. FDA Approval for DARZALEX® (daratumumab) in Combination with C...
GlobeNewswire 20/08/2020 Genmab Announces Plan to Transition Arzerra® (ofatumumab) to an Oncology Access Program for Chronic ...
GlobeNewswire 20/08/2020 U.S. FDA Approves Kesimpta® (ofatumumab) in Relapsing Multiple Sclerosis
GlobeNewswire 12/08/2020 Genmab Announces Financial Results for the First Half of 2020